Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's or Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01350258
What this trial is testing

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Who this might be right for
Hematologic MalignanciesAcute LeukemiaMyelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Testing effectiveness (Phase 2)Study completedNCT00079755
What this trial is testing

Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large-Cell Lymphoma
Seagen Inc. 80
Testing effectiveness (Phase 2)Study completedNCT00138164
What this trial is testing

Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 50
Early research (Phase 1)Study completedNCT03029338
What this trial is testing

CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

Who this might be right for
Lymphomas Non-Hodgkin's B-CellRelapse
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableStudy completedNCT00741325
What this trial is testing

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

Who this might be right for
Non-Hodgkin's LymphomaAutologous Transplantation
Genzyme, a Sanofi Company 178
Not applicableStudy completedNCT01272817
What this trial is testing

Nonmyeloablative Allogeneic Transplant

Who this might be right for
Aplastic AnemiaParoxysmal Nocturnal HemoglobinuriaAcute Myelogenous Leukemia+15 more
Scripps Health 36
Early research (Phase 1)Study completedNCT02453087
What this trial is testing

Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 66
Not applicableStudy completedNCT00606216
What this trial is testing

Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Undifferentiated Leukemia+3 more
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00048555
What this trial is testing

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 90
Early research (Phase 1)Ended earlyNCT02914938
What this trial is testing

ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Follicular Lymphoma (FL)+4 more
MEI Pharma, Inc. 97
Not applicableStudy completedNCT00031668
What this trial is testing

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 6
Large-scale testing (Phase 3)Study completedNCT01358747
What this trial is testing

Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL

Who this might be right for
Hodgkin's Lymphoma
Centre Hospitalier Universitaire Dijon
Very early researchEnded earlyNCT00515138
What this trial is testing

A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant

Who this might be right for
Lymphoma, B-Cell
University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT01733238
What this trial is testing

Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
Sierra Oncology LLC - a GSK company 13
Testing effectiveness (Phase 2)Study completedNCT01691898
What this trial is testing

Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Follicular LymphomaDiffuse Large B-Cell Lymphoma
Genentech, Inc. 231
Testing effectiveness (Phase 2)Ended earlyNCT00088881
What this trial is testing

Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+5 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT00186875
What this trial is testing

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoma, Lymphoblastic
St. Jude Children's Research Hospital 47
Early research (Phase 1)UnknownNCT05106907
What this trial is testing

Safety and Clinical Activity of ThisCART19 in Patients With r/r Non-Hodgkin's B Cell Lymphoma

Who this might be right for
B-cell Malignancy
Fundamenta Therapeutics, Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00467844
What this trial is testing

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Who this might be right for
Cachexia
GTx 159
Testing effectiveness (Phase 2)Study completedNCT01325701
What this trial is testing

Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell B-lymphoma
Pharmacyclics LLC. 78
Next Page